Li et al. [20] reported that serum FGF21 levels were significantly higher in the non-alcoholic fatty liver disease (NAFLD) group compared with the controls and had a high positive correlation with intrahepatic triglyceride content(r = 0.662, p<0.001). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.